Graves Light Lenhart Wealth’s Charles River Laboratories CRL Stock Holding History

Graves Light Lenhart Wealth’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-152	Closed	-$33K	–	256
2022 Q2	$33K	Sell	152 -493	-76%	-$120K	0.01%	350
2022 Q1	$183K	Sell	645 -11	-2%	-$3.39K	0.03%	185
2021 Q4	$247K	Hold	656	–	–	0.04%	170
2021 Q3	$271K	Sell	656 -23	-3%	-$9.55K	0.04%	153
2021 Q2	$251K	Sell	679 -20	-3%	-$6.68K	0.04%	155
2021 Q1	$203K	Sell	699 -16	-2%	-$4.45K	0.03%	177
2020 Q4	$179K	Buy	+715	New	+$170K	0.03%	178

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Graves Light Lenhart Wealth's CRL Position: Q3 2022 in Review

Graves Light Lenhart Wealth sold out of Charles River Laboratories (CRL) in Q3 2022, closing a stake of 152 shares — an estimated $33K sold.

Graves Light Lenhart Wealth first reported a position in CRL in Q4 2020 and held it in 7 quarters. The position peaked at $271K in Q3 2021. 582 funds tracked by Wall St. Rank hold CRL as of Q3 2022.

Graves Light Lenhart Wealth reported no remaining Charles River Laboratories position as of Q3 2022 after selling out during the quarter.
Graves Light Lenhart Wealth sold 152 Charles River Laboratories shares in Q3 2022, an estimated $33K.
Graves Light Lenhart Wealth first reported a position in Charles River Laboratories in Q4 2020 and held it in 7 quarters.
Graves Light Lenhart Wealth's Charles River Laboratories position peaked at $271K in Q3 2021.
582 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2022.

Based on Graves Light Lenhart Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.